Enable and promote research
Research to develop new diagnostics, drugs and vaccines
The limitations of the existing tools for diagnosis and treatment of TB - smear microscopy test and "short-course" chemotherapy - make standard TB care demanding for both patients and care providers. A truly effective vaccine is lacking. The need to rely on these tools has substantially hindered the pace of progress in global TB control. Facilitating the concerted efforts of the Stop TB Partnership's Working Groups on New Diagnostics, Drugs and Vaccines for TB is therefore a key component of the Stop TB Strategy. In the spirit of partnership, TB programmes should actively encourage and participate in this process. Countries should advocate new tools development, help speed up the field testing of new products, and prepare for swift adoption and roll out of new diagnostics, drugs and vaccines as they become available.